HomeINTS • NASDAQ
add
Intensity Therapeutics Inc
Previous close
$0.40
Day range
$0.39 - $0.42
Year range
$0.19 - $3.18
Market cap
23.98M USD
Avg Volume
59.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.73M | -23.45% |
Net income | -2.67M | 23.97% |
Net profit margin | — | — |
Earnings per share | -0.06 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.07M | 154.03% |
Total assets | 9.58M | 83.87% |
Total liabilities | 2.36M | -2.92% |
Total equity | 7.22M | — |
Shares outstanding | 60.06M | — |
Price to book | 2.64 | — |
Return on assets | -97.41% | — |
Return on capital | -141.62% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.67M | 23.97% |
Cash from operations | -2.39M | 39.90% |
Cash from investing | — | — |
Cash from financing | 7.24M | 1,652.54% |
Net change in cash | 4.85M | 1,156.86% |
Free cash flow | -1.42M | 43.64% |
About
Founded
2012
Headquarters
Website
Employees
5
